Ginkgo Bioworks Holdings, Inc. (DNA) Financials
DNA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 2.0 billion | 773.7 million |
2023-06-30 | 2.3 billion | 788.4 million |
2023-03-31 | 2.4 billion | 809.6 million |
2022-12-31 | 2.5 billion | 803.0 million |
DNA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -77.9 million | 52.6 million |
2023-06-30 | -87.1 million | 61.5 million |
2023-03-31 | -110.0 million | 73.0 million |
2022-12-31 | -130.3 million | 108.2 million |
DNA Net Income
No data available :(
DNA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 1.0 billion | - | 403.7 million |
2023-06-30 | 1.1 billion | - | 410.9 million |
2023-03-31 | 1.2 billion | - | 404.1 million |
2022-12-31 | 1.3 billion | - | 413.3 million |
DNA Shares Outstanding
DNA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 4.4 million | 156.7 million | 82.0 million | - |
2023-06-30 | 13.5 million | 144.3 million | 102.3 million | - |
2023-03-31 | 19.4 million | 162.6 million | 111.4 million | - |
2022-12-31 | 25.6 million | 181.2 million | 121.4 million | - |
DNA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 55.4 million | 6.9 million |
2023-06-30 | 80.6 million | 18.1 million |
2023-03-31 | 80.7 million | 22.4 million |
2022-12-31 | 98.3 million | 30.2 million |
DNA
Price: $0.93
52 week price:
Earnings Per Share: -0.46 USD
P/E Ratio: -3.68
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Volume: 21.0 million
Market Capitalization: 2.3 billion